With lockdowns behind us, CAJ continues to go about it's...

With lockdowns behind us, CAJ continues to go about it's business profitably and consistently pays a 3.5% dividend. (with franking credits this puts return around 4.3% not entirely shabby even with interest rates on the rise)

They've got a half decent footprint across four states now, with the majority concentration in and around Melbourne, and I don't sense any hangover with synergy issues.

Whilst I'm not enamoured with several of the Board members personally, the CEO is proven and a worker imo and there's some incentivised talent there too. Middle management is essential in a business like this and for mine they seem to be doing a solid job.

I've pretty much discounted Enlitic for now in terms of value-adding to SP, by association or return, although our clinics appear to have the latest tech and up to the minute training.... so,

What is the catalyst that will get this company moving in the eyes of the market? All thoughts welcome.